Exonic
AI for precision gene therapy
San Francisco, United States · Founded 2025 · $500K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- exonic.ai
- Total Funding
- $500K
- Last Round
- $500K SeedNov 2025
- Rounds
- 1
About
Exonic, backed by Y Combinator (F25), builds AI systems for precision gene therapy and the next generation of drug discovery. The company is focused on applying artificial intelligence to accelerate therapeutic development, with a strong focus on precision oncology. Based in San Francisco, Exonic raised $5M to support regulatory submissions and expand into new markets.
Summary
Exonic is a company based in San Francisco, United States, founded in 2025. It has raised $500K in total across 1 round, most recently a $500K Seed round in Nov 2025. Investors include Y Combinator Continuity Fund and Pioneer Fund.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
